The company seems to indicate that for now, the entire infectious diseases testing sector is in its addressable market. Any thoughts on that? Plus, is there reason to believe that the method can also be applied to cancer screening in the future?
The company seems to indicate that for now, the entire...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
65.0¢ |
Change
-0.030(4.41%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.0¢ | 65.0¢ | $26.35K | 39.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22897 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 56260 | 1 |
View Market Depth
| Last trade - 11.58am 04/12/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
